Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız:
http://hdl.handle.net/11452/25764
Tüm üstveri kaydı
Dublin Core Alanı | Değer | Dil |
---|---|---|
dc.date.accessioned | 2022-04-13T13:40:20Z | - |
dc.date.available | 2022-04-13T13:40:20Z | - |
dc.date.issued | 2012-05 | - |
dc.identifier.citation | Karalı, Y. vd. (2012). "Use of complementary and alternative medicine in children with cancer: Effect on survival". Pediatric Hematology and Oncology, 29(4), 335-344. | en_US |
dc.identifier.issn | 0888-0018 | - |
dc.identifier.uri | https://doi.org/10.3109/08880018.2012.670368 | - |
dc.identifier.uri | https://www.tandfonline.com/doi/full/10.3109/08880018.2012.670368 | - |
dc.identifier.uri | http://hdl.handle.net/11452/25764 | - |
dc.description.abstract | The objective of the present study was to determine the type, frequency, the reason why complementary and alternative medicine (CAM) treatments are used, the factors related with their use, and the effects of CAM usage on long-term survival. Families of a total of 120 children with cancer between 0-18 years of age, including 50 (41.7%) girls and 70 (58.3%) boys, participated in our study. The authors found that 88 patients (73.3%) used at least one CAM method, the most common (95.5%) of which was biologically based therapies. Most frequently used biologically based therapies were dietary supplements and herbal products. The most commonly used dietary supplement or herbal product was honey (43.2%) or stinging nettle (43.2%), respectively. We found that patients used such CAM methods as complementary to, but not instead of, conventional therapy. Sixty-nine out of 88 patient families (78.4%) shared the CAM method they used with their physicians. No statistically significant relation was found between socioeconomic, sociodemographic, or other factors or items and CAM use. The mean follow-up period of the CAM users and nonusers groups was 79.4 +/- 36.7 (21.3-217.9) and 90.9 +/- 50.3 (27.4-193.7) months, respectively. Five-year survival rates for CAM users and nonusers were found as 81.5% and 86.5%, respectively (P > .05). In conclusion, families of children with cancer use complementary and alternative treatment frequently. They do not attempt to replace conventional treatment with CAM. Higher rates of CAM use was found in families with higher educational level. CAM usage did not affect the long-term survival. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Oncology | en_US |
dc.subject | Hematology | en_US |
dc.subject | Pediatrics | en_US |
dc.subject | Alternative treatment | en_US |
dc.subject | Cancer | en_US |
dc.subject | Children | en_US |
dc.subject | Complementary medicine | en_US |
dc.subject | Pediatric oncology patients | en_US |
dc.subject | Therapies | en_US |
dc.subject | Turkey | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Child, preschool | en_US |
dc.subject.mesh | Complementary therapies | en_US |
dc.subject.mesh | Dietary supplements | en_US |
dc.subject.mesh | Disease-free survival | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Follow-up studies | en_US |
dc.subject.mesh | Honey | en_US |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Infant | en_US |
dc.subject.mesh | Infant, newborn | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Neoplasms | en_US |
dc.subject.mesh | Plants, medicinal | en_US |
dc.subject.mesh | Survival rate | en_US |
dc.subject.mesh | Urtica dioica | en_US |
dc.title | Use of complementary and alternative medicine in children with cancer: Effect on survival | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000303832800005 | tr_TR |
dc.identifier.scopus | 2-s2.0-84860850481 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Pediatri Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0003-0710-5422 | tr_TR |
dc.identifier.startpage | 335 | tr_TR |
dc.identifier.endpage | 344 | tr_TR |
dc.identifier.volume | 29 | tr_TR |
dc.identifier.issue | 4 | tr_TR |
dc.relation.journal | Pediatric Hematology and Oncology | en_US |
dc.contributor.buuauthor | Karalı, Yasin | - |
dc.contributor.buuauthor | Demirkaya, Metin | - |
dc.contributor.buuauthor | Sevinir, Betül | - |
dc.contributor.researcherid | C-7392-2019 | tr_TR |
dc.contributor.researcherid | AAH-1570-2021 | tr_TR |
dc.identifier.pubmed | 22568796 | tr_TR |
dc.subject.wos | Oncology | en_US |
dc.subject.wos | Hematology | en_US |
dc.subject.wos | Pediatrics | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q3 (Pediatrics) | en_US |
dc.wos.quartile | Q4 | en_US |
dc.contributor.scopusid | 49863694000 | tr_TR |
dc.contributor.scopusid | 24331130000 | tr_TR |
dc.contributor.scopusid | 6603199915 | tr_TR |
dc.subject.scopus | Complementary and Alternative Medicine; Homeopathy; Acupuncture | en_US |
dc.subject.emtree | Adolescent | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Alternative medicine | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Cancer survival | en_US |
dc.subject.emtree | Child | en_US |
dc.subject.emtree | Demography | en_US |
dc.subject.emtree | Diet supplementation | en_US |
dc.subject.emtree | Education | en_US |
dc.subject.emtree | Family | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Follow up | en_US |
dc.subject.emtree | Hodgkin disease | en_US |
dc.subject.emtree | Honey | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Infant | en_US |
dc.subject.emtree | Long term survival | en_US |
dc.subject.emtree | Major clinical study | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Nephroblastoma | en_US |
dc.subject.emtree | Neuroblastoma | en_US |
dc.subject.emtree | Newborn | en_US |
dc.subject.emtree | Nonhodgkin lymphoma | en_US |
dc.subject.emtree | Osteosarcoma | en_US |
dc.subject.emtree | Physician | en_US |
dc.subject.emtree | Preschool child | en_US |
dc.subject.emtree | School child | en_US |
dc.subject.emtree | Socioeconomics | en_US |
dc.subject.emtree | Soft tissue sarcoma | en_US |
dc.subject.emtree | Survival rate | en_US |
Koleksiyonlarda Görünür: | PubMed Scopus Web of Science |
Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.
DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.